<DOC>
	<DOCNO>NCT00100776</DOCNO>
	<brief_summary>The purpose study assess efficacy , safety , side effect among dos approve Food Drug Administration high ( FDA approve ) dos olanzapine patient schizophrenia schizoaffective disorder .</brief_summary>
	<brief_title>Efficacy High Dose Olanzapine Treatment Schizophrenia Schizoaffective Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>You must 18 60 year old You must diagnose schizophrenia schizoaffective disorder You must able visit doctor 's office 8 time 9 week period You must agree participate test examination require study You woman pregnant breastfeeding You presently acute unstable medical illness You history allergic reaction olanzapine You take medication permit study . Your physician discus You take part another clinical research trial within last 30 day receive treatment drug last 30 day receive regulatory approval .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>